Classer les publications sur l'année
-
Pharmaco-Epidémiologie
ENVOL study on the medical management of varicella and its complications in French ambulatory care
EMERY C, LANCON F, FAGNANI F, PECHEVIS M, DURAND I, FLORET D
Med Mal Infect ; 36(2):92-98
-
Ăconomie de la santĂ©
Cervical cancer screening and associated treatment costs in France
BERGERON C, BREUGELMANS JG, BOUEE S, LORANS C, BENARD S, REMY V
Gynécol Obstét Fertil ; 34:1036-1042
-
Santé publique
Bases dâune rĂ©gulation dĂ©mographique pour une spĂ©cialitĂ© chirurgicale : Les Chirurgiens OrthopĂ©distes en France
CATON J, DUBURCQ A
Revue de Chirurgie OrthopĂ©dique et RĂ©paratrice de lâAppareil ; 92(8):818-826
-
Pharmaco-Epidémiologie
Assessment of human papillomavirus testing with a liquid-based Cyto-screen (Âź) system for women with atypical squamous cells of undetermined significance effect of age
BERGERON C, CAS F, FAGNANI F, CONTREPAS A, WADIER R, POVEDA JD
Gynécol Obstét Fertil ; 34(4):312-316
-
Pharmaco-Epidémiologie
Air, pollution et cancer : baromĂštre de pollutions en France
NEROME S, QUOIX E, DUBURCQ A
Carnet de routes-Editions Bash ; 1-17
-
Pharmaco-Epidémiologie
A survey on the prevalence of orofacial herpes in France : The INSTANT Study
LORETTE G, CROCHARD A, MIMAUD V, WOLKENSTEIN P, STALDER JF, EL HASNAOUI A
J Am Acad Dermatol ; 55(2):225-232
-
Pharmaco-Epidémiologie
Venous thromboembolism and mortality after hip fracture surgery : The ESCORTE Study
ROSENCHER N, VIELPEAU C, EMMERICH J, FAGNANI F, SAMAMAÂ CM, The ESCORTE Group
J Thromb Haemost ; 3(9):2006-2014
-
Santé publique
Vaccination contre le papillomavirus bénéfices individuel et collectif
DETOURNAY B
Evaluation médico-économique du médicament ; 99-107
-
Ăconomie de la santĂ©
The economic burden of glaucoma and ocular hypertension
ROULAND JF, BERDEAUX G, LAFUMA A
Drugs Aging ; 22(4):315-321
-
Pharmaco-Epidémiologie
Results from the observational study EPIGRAM : management of excess weight in general practice and follow-up of patients treatd with orlistat
VRAY M, JOUBERT JM, ESCHWEGE E, LIARD F, FAGNANI F, MONTESTRUC F, FAGES S, BEGAUD B
Thérapie ; 60(1):153-162
-
Pharmaco-Epidémiologie
Prise en charge de la douleur en mĂ©decine gĂ©nĂ©rale : l’Ă©tude EPIDOL
EMERY C, GEORGE B, GOMAS JM, DELFIEU D, MIMAUD V, GUILLON P, FAGNANI F
Douleurs ; 6(6):366-373
-
Pharmaco-Epidémiologie
Prévalence de la bronchopneumopathie chronique obstructive (BPCO) : estimation pour la France
BENARD E, DETOURNAY B, NEUKIRCH F, PRIBIL C, EL HASNAOUI A
La Lettre du Pneumologue ; 8(4):158-163
-
Pharmaco-Epidémiologie
Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community : a nationwide survey
BREZIN AP, LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G
Arch Ophtalmol ; 123(8):1117-1124
-
Pharmaco-Epidémiologie
Prevalence and burden of self-reported blindness and low vision for individuals living in institutions : a nationwide survey
BREZIN AP, LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G
Health and Quality of Life Outcomes ; 3(27)
-
Santé publique
Methodological issues in determining the dimensionality of composite health measures using principal component analysis: Case illustration and suggestions for practice
COSTE J, BOUĂE S, ECOSSE E, LEPLĂGE A, POUCHOT J
Quality of life Research ; 14:641-654